ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 334 out of 2456

$380K Total Retail Price of All Prescriptions

Rank: 388 out of 2456

715 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 715 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 715 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 4,226 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 482 364 1 1
AMLODIPINE BESYLATE 343 250 2 5
OMEPRAZOLE 312 163 3 3
SIMVASTATIN 304 182 4 2
LEVOTHYROXINE SODIUM 270 145 5 4
PRAVASTATIN SODIUM 209 92 6 15
HYDROCHLOROTHIAZIDE 196 107 7 7
METOPROLOL TARTRATE 195 158 8 10
OXYCODONE-ACETAMINOPHEN 192 77 S2 9 35
METFORMIN HCL 187 79 10 11
FUROSEMIDE 154 90 11 8
ATORVASTATIN CALCIUM 154 126 11 12
PROAIR HFA 141 41 13 22
SERTRALINE HCL 121 50 14 21
ATENOLOL 113 96 15 6
HYDROCODONE-ACETAMINOPHEN 103 52 S3 16 20
LOSARTAN POTASSIUM 102 77 17 18
LOVASTATIN 99 87 18 34
WARFARIN SODIUM 96 83 19 9
GLIPIZIDE 95 64 20 46
GABAPENTIN 94 53 21 16
FLUTICASONE PROPIONATE 93 21 22 30
METOPROLOL SUCCINATE 84 45 23 13
GLIPIZIDE ER 83 64 24 89
LANTUS SOLOSTAR 78 42 25 136
OXYCODONE HCL 63 26 S2 26 38
TRAZODONE HCL 58 19 27 17
ALENDRONATE SODIUM 56 33 28 19
ZOLPIDEM TARTRATE 56 12 28 28
HUMALOG 55 35 30 123
DONEPEZIL HCL 53 45 31 23
CYCLOBENZAPRINE HCL 53 16 R 31 77
AMITRIPTYLINE HCL 52 0 R 33 83
BUPROPION HCL SR 50 0 34 119
ACETAMINOPHEN-CODEINE 50 28 S3 34 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.